Literature DB >> 16170514

Recurrent hepatoblastoma with localization by PET-CT.

Maria S Figarola1, Samuel A McQuiston, Felicia Wilson, Randall Powell.   

Abstract

Hepatoblastoma is the most common primary liver tumor in children, accounting for 79% of pediatric liver malignancies in children younger than 15 years, with most cases reported before the age of 5 years. Localization of primary and recurrent disease is necessary for appropriate clinical decision-making and treatment. We present a case of recurrent hepatoblastoma heralded by rising alpha-fetoprotein levels. After unsuccessful localization by conventional CT and MRI, positron emission tomography CT imaging localized the sites of recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170514     DOI: 10.1007/s00247-005-1568-6

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  5 in total

1.  The use of positron emission tomography in detecting hepatoblastoma recurrence--a cautionary tale.

Authors:  Kenneth K Y Wong; Lawrence C L Lan; Steve C L Lin; Paul K H Tam
Journal:  J Pediatr Surg       Date:  2004-12       Impact factor: 2.545

Review 2.  PET applications in pediatrics.

Authors:  B L Shulkin
Journal:  Q J Nucl Med       Date:  1997-12

Review 3.  Childhood cancers: hepatoblastoma.

Authors:  C E Herzog; R J Andrassy; F Eftekhari
Journal:  Oncologist       Date:  2000

4.  Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma.

Authors:  Tadashi Matsunaga; Fumiaki Sasaki; Mutsuro Ohira; Kohei Hashizume; Akira Hayashi; Yutaka Hayashi; Hideo Mugishima; Naomi Ohnuma
Journal:  Pediatr Surg Int       Date:  2003-05-24       Impact factor: 1.827

5.  Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.

Authors:  Jörg Fuchs; Jana Rydzynski; Dietrich Von Schweinitz; Udo Bode; Hartmut Hecker; Peter Weinel; Dietrich Bürger; Dieter Harms; Rudolf Erttmann; Karl Oldhafer; Hermann Mildenberger
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

  5 in total
  2 in total

1.  Is PET/CT necessary in paediatric oncology? Against.

Authors:  K Hahn; T Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

2.  A comparison between ¹⁸F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients.

Authors:  Angelina Cistaro; Giorgio Treglia; Manuela Pagano; Piercarlo Fania; Valentina Bova; Maria Eleonora Basso; Franca Fagioli; Umberto Ficola; Natale Quartuccio
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.